bf/NYSE:THC_icon.jpeg

COM:TENETHEALTH

Tenet Healthcare

  • Stock

Last Close

147.92

22/11 21:00

Market Cap

14.03B

Beta: -

Volume Today

2.27M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
207.50M
-
269M
29.64%
292.50M
8.74%
317.50M
8.55%
307.50M
3.15%
297M
3.41%
307.50M
3.54%
339M
10.24%
376M
10.91%
394.50M
4.92%
408M
3.42%
average payables
898.50M
-
1.13B
25.43%
1.28B
13.53%
1.35B
5.86%
1.25B
7.57%
1.19B
4.87%
1.21B
1.22%
1.21B
0%
1.25B
3.98%
1.40B
11.85%
1.46B
3.85%
average receivables
1.70B
-
2.22B
31.09%
2.56B
15.14%
2.81B
9.67%
2.76B
1.60%
2.62B
5.16%
2.68B
2.52%
2.72B
1.40%
2.73B
0.31%
2.86B
4.61%
3.47B
21.41%
book value per share
7.43
-
6.66
10.38%
6.97
4.68%
4.20
39.75%
-1.46
134.81%
-1.17
20.25%
-3.59
207.88%
0.27
107.43%
9.62
3,508.78%
10.68
10.99%
15.34
43.67%
capex per share
-6.80
-
-9.54
40.33%
-8.49
11.00%
-8.81
3.76%
-7.03
20.22%
-6.04
14.03%
-6.48
7.24%
-5.14
20.64%
-6.16
19.77%
-7.13
15.70%
-7.17
0.56%
capex to depreciation
-1.27
-
-1.10
13.33%
-1.06
3.87%
-1.03
2.56%
-0.81
21.06%
-0.77
5.33%
-0.79
2.46%
-0.63
20.06%
-0.77
22.14%
-0.91
17.73%
-0.86
4.73%
capex to operating cash flow
-1.17
-
-1.36
15.76%
-0.82
39.57%
-1.57
91.08%
-0.59
62.43%
-0.59
0.17%
-0.54
7.61%
-0.16
70.83%
-0.42
164.76%
-0.70
67.67%
-0.32
55.04%
capex to revenue
-0.06
-
-0.06
9.78%
-0.05
19.53%
-0.04
1.31%
-0.04
17.34%
-0.03
8.60%
-0.04
7.61%
-0.03
15.57%
-0.03
10.31%
-0.04
17.68%
-0.04
8.03%
cash per share
1.11
-
-0.59
153.35%
0.57
196.92%
4.53
688.25%
0.82
82.01%
-0.48
158.87%
2.53
628.03%
23.29
819.26%
22.13
5.00%
-6.17
127.89%
11.72
289.84%
days of inventory on hand
53.60
-
38.30
28.54%
38.06
0.63%
38.09
0.06%
34.19
10.23%
37.06
8.38%
37.01
0.12%
45.04
21.70%
42.12
6.50%
45.16
7.24%
8.28
81.67%
days payables outstanding
219.94
-
163.63
25.60%
170.00
3.89%
155.28
8.66%
139.02
10.47%
146.66
5.49%
143.76
1.98%
147.74
2.77%
142.58
3.49%
167.72
17.64%
28.36
83.09%
days sales outstanding
67.00
-
52.86
21.12%
53.10
0.47%
53.97
1.63%
49.88
7.57%
52.14
4.53%
54.38
4.29%
55.68
2.40%
51.89
6.81%
56.02
7.97%
70.93
26.61%
debt to assets
0.67
-
0.65
3.14%
0.61
5.86%
0.62
0.80%
0.64
3.43%
0.66
3.58%
0.63
4.52%
0.58
8.20%
0.57
2.17%
0.56
2.12%
0.53
4.04%
debt to equity
14.36
-
18.14
26.33%
21.00
15.78%
36.58
74.22%
-101.61
377.76%
-124.59
22.61%
-39.76
68.09%
561.39
1,511.95%
15.22
97.29%
13.20
13.24%
9.38
28.95%
dividend yield
earnings yield
-0.03
-
0.00
107.74%
-0.05
2,024.12%
-0.13
179.58%
-0.46
254.39%
0.06
113.74%
0.04
42.66%
0.18
403.66%
0.17
7.60%
0.19
13.26%
0.08
59.75%
enterprise value
15.01B
-
16.57B
10.41%
17.16B
3.56%
16.01B
6.68%
15.85B
1.01%
16.17B
1.98%
18.42B
13.96%
17.47B
5.19%
22.01B
26.01%
19.44B
11.68%
22.90B
17.83%
enterprise value over ebitda
11.18
-
8.49
24.09%
7.54
11.19%
6.64
11.98%
6.66
0.32%
6.30
5.30%
6.83
8.26%
5.52
19.20%
6.30
14.15%
5.59
11.25%
6.95
24.34%
ev to operating cash flow
25.48
-
24.12
5.34%
16.72
30.66%
28.70
71.59%
13.21
53.97%
15.41
16.66%
14.94
3.05%
5.13
65.69%
14.04
173.80%
17.95
27.87%
9.65
46.24%
ev to sales
1.35
-
1.00
26.23%
0.92
7.66%
0.82
11.37%
0.83
1.27%
0.88
6.80%
1.00
12.93%
0.99
0.68%
1.13
14.08%
1.01
10.25%
1.11
9.96%
free cash flow per share
-1.00
-
-2.52
150.66%
1.86
173.77%
-3.19
272.02%
4.90
253.56%
4.23
13.68%
5.44
28.70%
27.30
401.42%
8.52
68.80%
3.00
64.76%
15.49
415.88%
free cash flow yield
-0.02
-
-0.05
108.37%
0.06
223.36%
-0.22
451.22%
0.32
250.31%
0.25
23.65%
0.14
42.00%
0.68
377.56%
0.10
84.75%
0.06
40.99%
0.20
233.07%
graham net net
-130.18
-
-154.09
18.37%
-183.66
19.19%
-185.63
1.07%
-186.77
0.61%
-178.60
4.38%
-182.60
2.24%
-186.35
2.06%
-174.93
6.13%
-194.51
11.19%
-175.34
9.85%
graham number
14.84
-
4.29
71.12%
14.88
247.05%
13.51
9.17%
15.17
12.25%
5.34
64.80%
10.57
97.91%
6.62
37.31%
54.71
725.95%
47.41
13.35%
44.86
5.36%
income quality
-5.66
-
9.04
259.61%
13.15
45.52%
3.17
75.90%
-3.75
218.28%
2.25
160.03%
8.01
255.67%
4.44
44.59%
1.06
76.05%
1.08
1.84%
3.89
259.12%
intangibles to total assets
0.26
-
0.29
9.01%
0.37
27.57%
0.38
2.81%
0.38
0.09%
0.40
7.06%
0.38
5.72%
0.38
1.27%
0.39
1.59%
0.43
9.01%
0.41
3.02%
interest coverage
1.40
-
1.23
12.29%
1.16
5.62%
1.25
7.54%
1.08
13.05%
1.64
51.52%
1.54
6.36%
1.98
29.10%
3.11
56.85%
2.62
15.73%
2.69
2.76%
interest debt per share
111.30
-
128.43
15.40%
155.52
21.09%
163.45
5.10%
158.71
2.90%
155.03
2.32%
152.19
1.83%
159.24
4.63%
155.09
2.61%
149.34
3.71%
152.55
2.15%
inventory turnover
6.81
-
9.53
39.94%
9.59
0.63%
9.58
0.06%
10.67
11.39%
9.85
7.73%
9.86
0.12%
8.10
17.83%
8.67
6.95%
8.08
6.75%
44.09
445.57%
invested capital
14.36
-
18.14
26.33%
21.00
15.78%
36.58
74.22%
-101.61
377.76%
-124.59
22.61%
-39.76
68.09%
561.39
1,511.95%
15.22
97.29%
13.20
13.24%
9.38
28.95%
market cap
4.28B
-
4.96B
15.75%
3.00B
39.37%
1.47B
50.95%
1.52B
3.46%
1.75B
14.77%
3.93B
124.68%
4.19B
6.63%
8.73B
108.13%
5.22B
40.22%
7.92B
51.80%
net current asset value
-11.29B
-
-12.24B
8.35%
-15.29B
24.91%
-15.97B
4.46%
-15.41B
3.52%
-15.67B
1.68%
-16.28B
3.93%
-17.07B
4.85%
-16.25B
4.82%
-16.57B
1.97%
-15.64B
5.61%
net debt to ebitda
7.99
-
5.95
25.56%
6.22
4.52%
6.03
3.11%
6.02
0.14%
5.62
6.56%
5.37
4.51%
4.19
21.93%
3.80
9.35%
4.09
7.59%
4.55
11.19%
net income per share
-1.32
-
0.12
109.31%
-1.41
1,250.60%
-1.93
36.93%
-7.00
262.03%
1.09
115.53%
1.38
27.22%
7.31
428.82%
13.83
89.04%
9.35
32.36%
5.83
37.66%
operating cash flow per share
5.79
-
7.02
21.23%
10.35
47.29%
5.62
45.70%
11.93
112.34%
10.27
13.88%
11.92
16.08%
32.44
172.08%
14.68
54.76%
10.13
30.99%
22.65
123.66%
payables turnover
1.66
-
2.23
34.42%
2.15
3.75%
2.35
9.48%
2.63
11.69%
2.49
5.21%
2.54
2.02%
2.47
2.70%
2.56
3.62%
2.18
14.99%
12.87
491.40%
receivables turnover
5.45
-
6.91
26.77%
6.87
0.47%
6.76
1.60%
7.32
8.19%
7.00
4.33%
6.71
4.12%
6.56
2.34%
7.03
7.31%
6.52
7.38%
5.15
21.01%
research and ddevelopement to revenue
return on tangible assets
-0.01
-
0.00
108.23%
-0.01
1,104.74%
-0.01
33.64%
-0.05
287.51%
0.01
117.18%
0.01
19.05%
0.05
366.27%
0.09
90.91%
0.06
27.04%
0.04
42.68%
revenue per share
109.22
-
169.89
55.54%
187.91
10.61%
197.55
5.13%
190.66
3.49%
179.35
5.93%
178.72
0.35%
167.98
6.01%
182.39
8.57%
179.32
1.68%
196.07
9.34%
roe
-0.18
-
0.02
110.39%
-0.20
1,199.13%
-0.46
127.26%
4.79
1,140.14%
-0.93
119.48%
-0.39
58.68%
27.43
7,216.08%
1.44
94.76%
0.88
39.05%
0.38
56.61%
roic
0.03
-
0.05
47.06%
0.04
25.93%
0.06
54.83%
0.24
320.00%
0.08
65.97%
0.05
37.36%
0.14
184.41%
0.13
6.83%
0.11
20.56%
0.11
3.18%
sales general and administrative to revenue
0.48
-
0.48
0.19%
0.48
0.15%
0.48
1.39%
0.48
1.41%
0.47
2.50%
0.47
0.09%
0.48
1.31%
0.46
4.52%
0.46
1.23%
0.45
3.50%
shareholders equity per share
7.43
-
6.66
10.38%
6.97
4.68%
4.20
39.75%
-1.46
134.81%
-1.17
20.25%
-3.59
207.88%
0.27
107.43%
9.62
3,508.78%
10.68
10.99%
15.34
43.67%
stock based compensation to revenue
0.00
-
0.00
5.34%
0.00
20.63%
0.00
6.41%
0.00
11.24%
0.00
18.35%
0.00
9.52%
0.00
9.74%
0.00
15.22%
0.00
1.62%
0.00
9.98%
tangible asset value
-3.11B
-
-4.00B
28.82%
-5.42B
35.36%
-5.79B
6.90%
-6.38B
10.08%
-6.91B
8.25%
-6.87B
0.58%
-7.52B
9.53%
-6.50B
13.54%
-6.94B
6.74%
-6.17B
11.13%
tangible book value per share
-30.59
-
-40.95
33.89%
-54.67
33.49%
-58.35
6.73%
-63.41
8.69%
-67.62
6.64%
-66.39
1.82%
-71.60
7.85%
-60.85
15.01%
-64.89
6.64%
-58.85
9.32%
working capital
782M
-
1.14B
45.78%
863M
24.30%
1.22B
41.71%
1.24B
1.47%
779M
37.23%
876M
12.45%
2.30B
162.56%
1.97B
14.52%
1.50B
23.45%
2.41B
59.93%

All numbers in (except ratios and percentages)